Zobrazeno 1 - 10
of 61
pro vyhledávání: '"proteinase activated receptor 1"'
Publikováno v:
Thrombosis Research
bioRxiv
bioRxiv
COVID-19 has caused over 1 million deaths globally, yet the cellular mechanisms underlying severe disease remain poorly understood. By analyzing several thousand plasma proteins in 306 COVID-19 patients and 78 symptomatic controls over serial timepoi
Publikováno v:
Journal of Biomaterials and Tissue Engineering. 9:599-606
To study thrombin (TM) damage effect and detailed quantitative relation on cerebral vessels function, and to explore inflammatory mechanism of TM on cerebral vasospasm (CVS) in vivo. Wild type SD rats were randomly assigned into different groups for
Publikováno v:
American Journal of Physiology-Cell Physiology. 316:C377-C392
Activated coagulation factor XI (FXIa) is a serine proteinase that plays a key role in the intrinsic coagulation pathway. The analysis of FXI-knockout mice has indicated the contribution of FXI to the pathogenesis of atherosclerosis. However, the und
Autor:
David A. Goukassian, Lahouaria Hadri, Kenneth Fish, Malik Bisserier, Walid Hamouche, Abrisham Eskandari, Agnieszka Brojakowska
Publikováno v:
Journal of Molecular and Cellular Cardiology
The first confirmed case of novel Coronavirus Disease 2019 (COVID-19) in the United States was reported on January 20, 2020. As of November 24, 2020, close to 12.2 million cases of COVID-19 was confirmed in the US, with over 255,958 deaths. The rapid
Publikováno v:
Journal of applied physiology (Bethesda, Md. : 1985). 127(6)
In situ thrombus formation is one of the major pathological features of pulmonary hypertension (PH). The mechanism of in situ thrombosis has not been clearly identified. Fibrinogen-like protein 2 (FGL2) prothrombinase is an immune coagulant that can
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:2-O
Autor:
Toby M. Maher
Publikováno v:
Clinics in Chest Medicine. 33:69-83
Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown cause that conveys a dismal prognosis. In the United States there are currently no licensed therapies for treatment of IPF. The development of effective IPF clinical trials netwo
Publikováno v:
Journal of Pharmacological Sciences, Vol 108, Iss 4, Pp 426-432 (2008)
Cerebral vasospasm is one of the major complications of subarachnoid hemorrhage (SAH). The prevention and treatment of cerebral vasospasm thus plays a critical role in the management of SAH patients. However, the mechanism of cerebral vasospasm still
Autor:
Panagiota Zania, Christodoulos S. Flordellis, M. E. Papaconstantinou, Michael E. Maragoudakis, Nikos E. Tsopanoglou
Publikováno v:
American Journal of Physiology-Cell Physiology. 294:C1215-C1226
Thrombin has been reported to play a pivotal role in the initiation of angiogenesis by indirectly regulating and organizing a network of angiogenic molecules. In addition, it has been proposed that thrombin can directly activate endothelial cell prol
Publikováno v:
American Journal of Physiology-Cell Physiology. 284:C1185-C1192
Subepithelial myofibroblast-derived prostaglandin E2(PGE2) regulates epithelial chloride secretion in the intestine. Thrombin is elevated in inflammatory conditions of the bowel. Therefore, we sought to determine a role for thrombin in regulating PGE